Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease

Background/Aim. Introduction of acetylcholine esterase inhibitors as a symptomatic treatment of Alzheimer's disease (AD) has additionally highlighted the importance of diagnostic markers in cerebrospinal fluid (CSF) for early AD diagnosis: low level of 42 amino acid form of amyloid-β peptide (A...

Full description

Saved in:
Bibliographic Details
Main Authors: Mandić Gorana, Marković Ivanka, Ostojić Marija, Stojković Tanja, Misirlić-Denčić Sonja, Živanović-Radnić Tatjana, Stefanović Rodoljub, Bumbaširević Marko, Stefanova Elka, Kostić Vladimir
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2008-01-01
Series:Vojnosanitetski Pregled
Subjects:
Alzheimer disease
cerebrospinal fluid
biologicalmarkers
amyloid beta-protein
tau proteins
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500812901M.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500812901M.pdf

Similar Items